
Sign up to save your podcasts
Or


On this episode of MedTech Smarts with Rita, MethodSense founder and CEO Rita King joins Anna Crooke to take a closer look at one of the most talked about advancements at the FDA: their new artificial intelligence tool, Elsa. Anna and Rita break down what Elsa means for MedTech executives, why it’s making waves in the industry, and how this tool could shape the future of medical device regulation.
By MethodSense + Rita KingOn this episode of MedTech Smarts with Rita, MethodSense founder and CEO Rita King joins Anna Crooke to take a closer look at one of the most talked about advancements at the FDA: their new artificial intelligence tool, Elsa. Anna and Rita break down what Elsa means for MedTech executives, why it’s making waves in the industry, and how this tool could shape the future of medical device regulation.